Isaksen

TL3 Regular · Nice, FR

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 26 September 2024 · last posted 4h · groups: pharmacists

2 replies marked as the accepted answer.

Follow-up: Open-label extensions: what survives and what does not Replied, post #8 · marked as the solution · Evidence › Trials · 9 Mar 2025 · 18 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
Signs of dehydration worth acting on Replied, post #5 · marked as the solution · Safety › Adverse events · 14 Aug 2024 · 31 likes Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance…